New Trends in Cardiovascular and Liver Tumor Treatment: Cutting-Edge Technologies at Zhongshan Hospital

Cutting-Edge Technologies at Zhongshan Hospital: New Heights in Cardiovascular and Liver Tumor Care

Fudan University-affiliated Zhongshan Hospital continues to lead in the diagnosis and treatment of cardiovascular diseases and liver tumors, with multiple technological innovations changing treatment choices for international patients.

Minimally Invasive Cardiovascular Intervention

Transcatheter aortic valve replacement (TAVR) is now widely used in elderly and high-risk patients with aortic stenosis, with less trauma and faster recovery. The hospital also leads in complex coronary intervention and atrial fibrillation ablation. Hybrid operating rooms enable one-stop solutions for complex cases.

Precision Liver Tumor Treatment

Zhongshan Hospital's liver cancer treatment adopts a multidisciplinary model, combining surgical resection, interventional therapy, ablation, targeted and immunotherapy to develop individualized plans for patients at different stages. Intraoperative ultrasound and three-dimensional reconstruction make surgery more precise, and minimally invasive and enhanced recovery concepts shorten hospital stays.

Application of Surgical Robots

Robot-assisted surgery is increasingly mature in liver and cardiac surgery, with more precise operation and clearer vision, helping protect important tissues and reduce complications.

Significance for International Patients

For international patients, advanced technology means less trauma, shorter recovery and higher safety. Combined with multilingual services at the international medical department, patients can confidently receive precision treatment aligned with international standards.

Conclusion

Technology is the core driving force of medical care. Zhongshan Hospital provides better treatment choices for cardiovascular and liver tumor patients around the world through cutting-edge technology.